Excellent 4.6 out of 5
Infectious Diseases

Alcoholic Liver Disease

Alcoholic Liver Disease disrupts hepatocyte function, bile flow, and protein synthesis. Biomarker testing clarifies injury and reserve. At Superpower, we test for AST, ALT, GGT, Bilirubin, and Albumin to track hepatocellular damage, cholestasis, and synthetic capacity—helping map liver system health before complications.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for Alcoholic Liver Disease
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Benefits

  • Check how alcohol affects and stresses your liver.
  • Spot early injury and alcohol patterns; AST, ALT, GGT rise, AST:ALT >2.
  • Explain jaundice or dark urine; bilirubin reflects bile flow issues or damage.
  • Gauge liver reserve and nutrition; albumin shows protein-making capacity and chronic disease.
  • Best interpreted with INR, platelets, ultrasound, and your symptoms for severity.
  • Guide safer treatment choices; adjust medications and supplements to protect liver.
  • Track recovery with abstinence; falling enzymes and GGT signal healing over weeks.
  • Support fertility and pregnancy planning; stabilize liver health before conception and prenatal care.

What are Alcoholic Liver Disease

Alcoholic liver disease biomarkers are measurable signals from the liver and blood that translate drinking’s impact into a biological story you can track. They show recent alcohol exposure (direct ethanol metabolites such as phosphatidylethanol, ethyl glucuronide, and carbohydrate-deficient transferrin), liver cell stress and injury (hepatocellular damage: AST, ALT, GGT), bile flow disruption (cholestasis: alkaline phosphatase and bilirubin), scar formation and tissue remodeling (fibrosis: hyaluronic acid, procollagen III peptide), and the liver’s factory output (synthetic function: albumin and clotting proteins). Together, they reveal where someone sits on the spectrum from reversible inflammation to established scarring, often before symptoms are obvious. Testing enables earlier recognition of harmful drinking, more precise staging of disease, and objective monitoring of abstinence and recovery over time. It also guides treatment intensity—supporting decisions about counseling, nutrition, and medication—and helps clinicians anticipate complications by showing whether injury is ongoing, bile is backing up, or the liver’s production capacity is faltering. In short, these biomarkers turn hidden liver stress into actionable information.

Why are Alcoholic Liver Disease biomarkers important?

Alcoholic Liver Disease biomarkers are the liver’s dashboard: they show cell injury (AST, ALT), bile flow and alcohol-related enzyme induction (GGT), bilirubin handling, and the liver’s protein-making capacity (albumin). Because the liver regulates metabolism, detoxification, hormones, clotting, and fluid balance, changes here ripple across the brain, gut, immune, endocrine, and cardiovascular systems.

Typical reference ranges: AST about 10–40, ALT 7–56, GGT 10–60, total bilirubin 0.1–1.2, albumin 3.5–5.0. For organ health, AST, ALT, and GGT are best at the low end of normal; bilirubin tends to be optimal low-to-mid; albumin is healthiest mid-to-high. In Alcoholic Liver Disease, AST usually exceeds ALT (often by more than twofold), GGT rises with enzyme induction and cholestasis, bilirubin climbs with jaundice and dark urine, and albumin falls as synthetic function declines—manifesting as edema, ascites, fatigue, muscle loss, and bruising. Women can develop these abnormalities at lower alcohol exposure than men; adolescents generally have lower baseline ALT/AST.

When values are low, AST, ALT, GGT, and bilirubin typically reflect minimal current injury and unobstructed bile flow—reassuring for Alcoholic Liver Disease activity. Low albumin is different: it signals impaired hepatic protein synthesis or poor nutrition, worsening swelling, orthostatic lightheadedness, and frailty; during pregnancy, albumin runs lower from hemodilution rather than liver failure.

Big picture: these markers map liver inflammation, cholestasis, and synthesis—the forces that drive fibrosis, cirrhosis, portal hypertension, and encephalopathy. Patterns like AST:ALT >2 and elevated GGT also track oxidative stress and cardiometabolic risk. Watching them together links liver status to whole-body outcomes and long-term survival.

What Insights Will I Get?

Alcoholic liver disease (ALD) testing matters because the liver powers energy production, regulates metabolism, shapes cholesterol and glucose balance, clears toxins and drugs, builds proteins for blood and immunity, and maintains hormone and micronutrient homeostasis. Damage from alcohol disrupts these systems. At Superpower, we test AST, ALT, GGT, Bilirubin, and Albumin.

AST and ALT are enzymes inside liver cells (aminotransferases). When cells are injured, they leak into blood; in ALD, AST typically rises more than ALT (often a ratio >2), reflecting mitochondrial injury and B6 depletion. GGT is a membrane enzyme induced by alcohol and bile duct stress; it rises with alcohol exposure and cholestasis. Bilirubin is the breakdown pigment of hemoglobin; elevated levels signal impaired uptake, processing, or excretion by the liver (hepatocellular dysfunction or bile flow blockage). Albumin is the main blood protein made by the liver; it reflects synthetic capacity and oncotic pressure.

For stability, low and steady AST/ALT suggest little ongoing injury; abrupt or persistent elevations signal active damage. An AST-dominant pattern with elevated GGT supports alcohol-related injury; falling values suggest recovery. Normal bilirubin indicates preserved excretory function; rising bilirubin indicates worsening cholestasis or hepatocellular failure. Normal albumin indicates good reserve; low albumin points to chronic dysfunction and fragility of the system.

Notes: Interpretation is influenced by age, sex, pregnancy (lower albumin), body habitus, recent strenuous exercise or muscle injury (raises AST/ALT), hemolysis or Gilbert syndrome (alters bilirubin), heart failure and sepsis, obesity/NAFLD, and medications or alcohol-inducing enzymes (notably GGT). Assay methods and lab reference intervals vary.

Superpower also tests for

See more diseases

Frequently Asked Questions About Alcoholic Liver Disease

What is Alcoholic Liver Disease testing?

Alcoholic Liver Disease testing is a blood panel that checks how alcohol is affecting your liver’s cells and its core jobs. Superpower measures AST and ALT for liver cell injury (hepatocellular injury), GGT for alcohol-related enzyme induction and bile flow problems (cholestasis), bilirubin for waste excretion, and albumin for protein-making capacity (synthetic function). The pattern across these markers helps flag alcohol-related inflammation or damage, estimate severity, and guide next steps. No single marker proves Alcoholic Liver Disease; results are interpreted together and in context.

Why should I get Alcoholic Liver Disease biomarker testing?

Because alcohol-related liver injury is often silent until advanced. This panel can detect early harm, track active inflammation, and gauge whether liver function is preserved. AST/ALT rise with cell injury, GGT rises with alcohol exposure or cholestasis, bilirubin and albumin reflect excretory and synthetic capacity—key indicators of progression toward fibrosis or cirrhosis. Testing establishes a baseline, quantifies risk, and monitors change over time so complications can be anticipated rather than surprised.

How often should I test?

Use a cadence that captures change without over-testing. For ongoing alcohol exposure or known liver disease, checking every 3–6 months is reasonable. After a major change in alcohol use or starting/stopping potentially hepatotoxic medications, retest in about 6–12 weeks to assess the new steady state. If results are markedly abnormal or symptoms develop, testing may be needed more often in clinical care. Stable, low-risk situations may only need periodic baseline checks.

What can affect biomarker levels?

Recent alcohol intake can transiently raise AST and GGT. Medications and supplements that stress the liver (for example, acetaminophen, statins, antiepileptics) can shift values. Hard exercise or muscle injury elevates AST. Bile duct problems increase GGT and bilirubin. Fasting, hemolysis, or Gilbert syndrome raise unconjugated bilirubin. Pregnancy, inflammation, and malnutrition lower albumin. Fatty liver from metabolic factors can raise ALT. Intercurrent infections and dehydration can nudge multiple markers. Always consider timing, exposures, and non-liver causes.

Are there any preparations needed before Alcoholic Liver Disease biomarker testing?

No special preparation is usually required. Fasting is not needed for AST, ALT, GGT, bilirubin, or albumin. Avoid heavy exercise for 24–48 hours, as it can raise AST. Avoid alcohol for at least 24 hours because it can acutely alter GGT and transaminases. Take your usual medications unless your clinician has advised otherwise, but know that some drugs can affect results. Stay well hydrated, and try to use the same time of day for repeat testing to improve comparability.

Can lifestyle changes affect my biomarker levels?

Yes. Changes in alcohol intake directly influence GGT and often AST/ALT; lower exposure tends to lower these enzymes, while renewed or heavy exposure raises them. Improvements in metabolic health and weight can reduce ALT, while poor nutrition or systemic inflammation can lower albumin. Sleep, hydration, and physical activity patterns can cause smaller shifts. These biomarkers are responsive, so trends will reflect sustained changes in physiology rather than day-to-day noise.

How do I interpret my results?

Think in patterns and trends. Elevated AST/ALT indicate liver cell injury; an AST-to-ALT ratio greater than 2 leans toward alcoholic hepatitis but is not definitive. Elevated GGT supports alcohol exposure or cholestasis, yet it is nonspecific. Rising bilirubin or low albumin signals impaired liver function and suggests more advanced disease. Normal values do not exclude early Alcoholic Liver Disease. A baseline and serial measurements provide the clearest picture of trajectory when interpreted with your clinical context.

How do I interpret my results?

Think in patterns and trends. Elevated AST/ALT indicate liver cell injury; an AST-to-ALT ratio greater than 2 leans toward alcoholic hepatitis but is not definitive. Elevated GGT supports alcohol exposure or cholestasis, yet it is nonspecific. Rising bilirubin or low albumin signals impaired liver function and suggests more advanced disease. Normal values do not exclude early Alcoholic Liver Disease. A baseline and serial measurements provide the clearest picture of trajectory when interpreted with your clinical context.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start testing
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you